Targeting Multiple Myeloma with AMG 424, a Novel Anti-CD38/CD3 Bispecific T-cell–recruiting Antibody Optimized for Cytotoxicity and Cytokine Release - Concepedia

Concepedia

Publication | Closed Access

Targeting Multiple Myeloma with AMG 424, a Novel Anti-CD38/CD3 Bispecific T-cell–recruiting Antibody Optimized for Cytotoxicity and Cytokine Release

123

Citations

40

References

2019

Year

Christina L. Zuch de Zafra, Flordeliza Fajardo, Wendy Zhong, Matthew J. Bernett, Umesh S. Muchhal, Gregory L. Moore, Jennitte Stevens, Ryan Case, Joshua T. Pearson, Siyuan Liu,

Clinical Cancer Research

Abstract

These findings support the clinical development of AMG 424, an affinity-optimized T-cell-recruiting antibody with the potential to elicit significant clinical activity in patients with multiple myeloma.

References

	Year	Citations

Page 1